Wogonin ameliorates the proliferation, inflammatory response, and pyroptosis in keratinocytes via NOD‐like receptor family pyrin domain containing 3/Caspase‐1/Gasdermin‐D pathway

Background Psoriasis refers to a highly prevalent and immunologically mediated dermatosis with considerable deterioration in life quality. Wogonin, a sort of flavonoid, has been mentioned to elicit protective activities in skin diseases. However, whether Wogonin is implicated in the treatment of pso...

Full description

Saved in:
Bibliographic Details
Published inImmunity, Inflammation and Disease Vol. 12; no. 7; pp. e1303 - n/a
Main Authors Ma, Jun, Ji, Chen, Sun, Yanhong, Liu, Danqing, Pan, Kai, Wei, Yuegang
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.07.2024
John Wiley and Sons Inc
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Psoriasis refers to a highly prevalent and immunologically mediated dermatosis with considerable deterioration in life quality. Wogonin, a sort of flavonoid, has been mentioned to elicit protective activities in skin diseases. However, whether Wogonin is implicated in the treatment of psoriasis and its specific mechanisms are not fully understood. Aim The present work attempted to elaborate the role of Wogonin during the process of psoriasis and to concentrate on the associated action mechanism. Methods Cell counting kit‐8 (CCK‐8) method was initially applied to assay the viability of human keratinocyte HaCaT cells treated by varying concentrations of Wogonin. To mimic psoriasis in vitro, HaCaT cells were exposed to M5 cytokines. CCK‐8 and 5‐Ethynyl‐2′‐deoxyuridine  assays were adopted for the measurement of cell proliferation. Inflammatory levels were examined with enzyme‐linked immunosorbent assay. Immunofluorescence staining tested nucleotide‐binding oligomerization domain (NOD)‐like receptor family pyrin domain containing 3 (NLRP3) and Caspase‐1 expressions. Western blot examined the protein expressions of proliferation‐, inflammation‐, pyroptosis‐associated factors, and NLRP3. Results Wogonin treatment antagonized the proliferation, inflammatory response, and NLRP3/caspase‐1/Gasdermin‐D (GSDMD)‐mediated pyroptosis in M5‐challenged HaCaT cells. Besides, NLRP3 elevation partially abrogated the effects of Wogonin on M5‐induced proliferation, inflammatory response, and NLRP3/caspase‐1/GSDMD‐mediated pyroptosis in HaCaT cells. Conclusion In a word, Wogonin might exert anti‐proliferation, anti‐inflammatory and anti‐pyroptosis activities in M5‐induced cell model of psoriasis and the blockade of NLRP3/Caspase‐1/GSDMD pathway might be recognized as a potential mechanism underlying the protective mechanism of Wogonin in psoriasis, suggesting Wogonin as a prospective anti‐psoriasis drug. Wogonin was capable of alleviating the hyperproliferation, inflammatory response as well as pyroptosis in HaCaT keratinocytes exposed to M5 cytokines, the effects of which might be related to the blockade of NOD‐like receptor family pyrin domain containing 3/Caspase‐1/Gasdermin‐D  pathway.
AbstractList Background Psoriasis refers to a highly prevalent and immunologically mediated dermatosis with considerable deterioration in life quality. Wogonin, a sort of flavonoid, has been mentioned to elicit protective activities in skin diseases. However, whether Wogonin is implicated in the treatment of psoriasis and its specific mechanisms are not fully understood. Aim The present work attempted to elaborate the role of Wogonin during the process of psoriasis and to concentrate on the associated action mechanism. Methods Cell counting kit‐8 (CCK‐8) method was initially applied to assay the viability of human keratinocyte HaCaT cells treated by varying concentrations of Wogonin. To mimic psoriasis in vitro, HaCaT cells were exposed to M5 cytokines. CCK‐8 and 5‐Ethynyl‐2′‐deoxyuridine  assays were adopted for the measurement of cell proliferation. Inflammatory levels were examined with enzyme‐linked immunosorbent assay. Immunofluorescence staining tested nucleotide‐binding oligomerization domain (NOD)‐like receptor family pyrin domain containing 3 (NLRP3) and Caspase‐1 expressions. Western blot examined the protein expressions of proliferation‐, inflammation‐, pyroptosis‐associated factors, and NLRP3. Results Wogonin treatment antagonized the proliferation, inflammatory response, and NLRP3/caspase‐1/Gasdermin‐D (GSDMD)‐mediated pyroptosis in M5‐challenged HaCaT cells. Besides, NLRP3 elevation partially abrogated the effects of Wogonin on M5‐induced proliferation, inflammatory response, and NLRP3/caspase‐1/GSDMD‐mediated pyroptosis in HaCaT cells. Conclusion In a word, Wogonin might exert anti‐proliferation, anti‐inflammatory and anti‐pyroptosis activities in M5‐induced cell model of psoriasis and the blockade of NLRP3/Caspase‐1/GSDMD pathway might be recognized as a potential mechanism underlying the protective mechanism of Wogonin in psoriasis, suggesting Wogonin as a prospective anti‐psoriasis drug. Wogonin was capable of alleviating the hyperproliferation, inflammatory response as well as pyroptosis in HaCaT keratinocytes exposed to M5 cytokines, the effects of which might be related to the blockade of NOD‐like receptor family pyrin domain containing 3/Caspase‐1/Gasdermin‐D  pathway.
Abstract Background Psoriasis refers to a highly prevalent and immunologically mediated dermatosis with considerable deterioration in life quality. Wogonin, a sort of flavonoid, has been mentioned to elicit protective activities in skin diseases. However, whether Wogonin is implicated in the treatment of psoriasis and its specific mechanisms are not fully understood. Aim The present work attempted to elaborate the role of Wogonin during the process of psoriasis and to concentrate on the associated action mechanism. Methods Cell counting kit‐8 (CCK‐8) method was initially applied to assay the viability of human keratinocyte HaCaT cells treated by varying concentrations of Wogonin. To mimic psoriasis in vitro, HaCaT cells were exposed to M5 cytokines. CCK‐8 and 5‐Ethynyl‐2′‐deoxyuridine  assays were adopted for the measurement of cell proliferation. Inflammatory levels were examined with enzyme‐linked immunosorbent assay. Immunofluorescence staining tested nucleotide‐binding oligomerization domain (NOD)‐like receptor family pyrin domain containing 3 (NLRP3) and Caspase‐1 expressions. Western blot examined the protein expressions of proliferation‐, inflammation‐, pyroptosis‐associated factors, and NLRP3. Results Wogonin treatment antagonized the proliferation, inflammatory response, and NLRP3/caspase‐1/Gasdermin‐D (GSDMD)‐mediated pyroptosis in M5‐challenged HaCaT cells. Besides, NLRP3 elevation partially abrogated the effects of Wogonin on M5‐induced proliferation, inflammatory response, and NLRP3/caspase‐1/GSDMD‐mediated pyroptosis in HaCaT cells. Conclusion In a word, Wogonin might exert anti‐proliferation, anti‐inflammatory and anti‐pyroptosis activities in M5‐induced cell model of psoriasis and the blockade of NLRP3/Caspase‐1/GSDMD pathway might be recognized as a potential mechanism underlying the protective mechanism of Wogonin in psoriasis, suggesting Wogonin as a prospective anti‐psoriasis drug.
Wogonin was capable of alleviating the hyperproliferation, inflammatory response as well as pyroptosis in HaCaT keratinocytes exposed to M5 cytokines, the effects of which might be related to the blockade of NOD‐like receptor family pyrin domain containing 3/Caspase‐1/Gasdermin‐D  pathway.
Psoriasis refers to a highly prevalent and immunologically mediated dermatosis with considerable deterioration in life quality. Wogonin, a sort of flavonoid, has been mentioned to elicit protective activities in skin diseases. However, whether Wogonin is implicated in the treatment of psoriasis and its specific mechanisms are not fully understood.BACKGROUNDPsoriasis refers to a highly prevalent and immunologically mediated dermatosis with considerable deterioration in life quality. Wogonin, a sort of flavonoid, has been mentioned to elicit protective activities in skin diseases. However, whether Wogonin is implicated in the treatment of psoriasis and its specific mechanisms are not fully understood.The present work attempted to elaborate the role of Wogonin during the process of psoriasis and to concentrate on the associated action mechanism.AIMThe present work attempted to elaborate the role of Wogonin during the process of psoriasis and to concentrate on the associated action mechanism.Cell counting kit-8 (CCK-8) method was initially applied to assay the viability of human keratinocyte HaCaT cells treated by varying concentrations of Wogonin. To mimic psoriasis in vitro, HaCaT cells were exposed to M5 cytokines. CCK-8 and 5-Ethynyl-2'-deoxyuridine assays were adopted for the measurement of cell proliferation. Inflammatory levels were examined with enzyme-linked immunosorbent assay. Immunofluorescence staining tested nucleotide-binding oligomerization domain (NOD)-like receptor family pyrin domain containing 3 (NLRP3) and Caspase-1 expressions. Western blot examined the protein expressions of proliferation-, inflammation-, pyroptosis-associated factors, and NLRP3.METHODSCell counting kit-8 (CCK-8) method was initially applied to assay the viability of human keratinocyte HaCaT cells treated by varying concentrations of Wogonin. To mimic psoriasis in vitro, HaCaT cells were exposed to M5 cytokines. CCK-8 and 5-Ethynyl-2'-deoxyuridine assays were adopted for the measurement of cell proliferation. Inflammatory levels were examined with enzyme-linked immunosorbent assay. Immunofluorescence staining tested nucleotide-binding oligomerization domain (NOD)-like receptor family pyrin domain containing 3 (NLRP3) and Caspase-1 expressions. Western blot examined the protein expressions of proliferation-, inflammation-, pyroptosis-associated factors, and NLRP3.Wogonin treatment antagonized the proliferation, inflammatory response, and NLRP3/caspase-1/Gasdermin-D (GSDMD)-mediated pyroptosis in M5-challenged HaCaT cells. Besides, NLRP3 elevation partially abrogated the effects of Wogonin on M5-induced proliferation, inflammatory response, and NLRP3/caspase-1/GSDMD-mediated pyroptosis in HaCaT cells.RESULTSWogonin treatment antagonized the proliferation, inflammatory response, and NLRP3/caspase-1/Gasdermin-D (GSDMD)-mediated pyroptosis in M5-challenged HaCaT cells. Besides, NLRP3 elevation partially abrogated the effects of Wogonin on M5-induced proliferation, inflammatory response, and NLRP3/caspase-1/GSDMD-mediated pyroptosis in HaCaT cells.In a word, Wogonin might exert anti-proliferation, anti-inflammatory and anti-pyroptosis activities in M5-induced cell model of psoriasis and the blockade of NLRP3/Caspase-1/GSDMD pathway might be recognized as a potential mechanism underlying the protective mechanism of Wogonin in psoriasis, suggesting Wogonin as a prospective anti-psoriasis drug.CONCLUSIONIn a word, Wogonin might exert anti-proliferation, anti-inflammatory and anti-pyroptosis activities in M5-induced cell model of psoriasis and the blockade of NLRP3/Caspase-1/GSDMD pathway might be recognized as a potential mechanism underlying the protective mechanism of Wogonin in psoriasis, suggesting Wogonin as a prospective anti-psoriasis drug.
Psoriasis refers to a highly prevalent and immunologically mediated dermatosis with considerable deterioration in life quality. Wogonin, a sort of flavonoid, has been mentioned to elicit protective activities in skin diseases. However, whether Wogonin is implicated in the treatment of psoriasis and its specific mechanisms are not fully understood. The present work attempted to elaborate the role of Wogonin during the process of psoriasis and to concentrate on the associated action mechanism. Cell counting kit-8 (CCK-8) method was initially applied to assay the viability of human keratinocyte HaCaT cells treated by varying concentrations of Wogonin. To mimic psoriasis in vitro, HaCaT cells were exposed to M5 cytokines. CCK-8 and 5-Ethynyl-2'-deoxyuridine  assays were adopted for the measurement of cell proliferation. Inflammatory levels were examined with enzyme-linked immunosorbent assay. Immunofluorescence staining tested nucleotide-binding oligomerization domain (NOD)-like receptor family pyrin domain containing 3 (NLRP3) and Caspase-1 expressions. Western blot examined the protein expressions of proliferation-, inflammation-, pyroptosis-associated factors, and NLRP3. Wogonin treatment antagonized the proliferation, inflammatory response, and NLRP3/caspase-1/Gasdermin-D (GSDMD)-mediated pyroptosis in M5-challenged HaCaT cells. Besides, NLRP3 elevation partially abrogated the effects of Wogonin on M5-induced proliferation, inflammatory response, and NLRP3/caspase-1/GSDMD-mediated pyroptosis in HaCaT cells. In a word, Wogonin might exert anti-proliferation, anti-inflammatory and anti-pyroptosis activities in M5-induced cell model of psoriasis and the blockade of NLRP3/Caspase-1/GSDMD pathway might be recognized as a potential mechanism underlying the protective mechanism of Wogonin in psoriasis, suggesting Wogonin as a prospective anti-psoriasis drug.
Background Psoriasis refers to a highly prevalent and immunologically mediated dermatosis with considerable deterioration in life quality. Wogonin, a sort of flavonoid, has been mentioned to elicit protective activities in skin diseases. However, whether Wogonin is implicated in the treatment of psoriasis and its specific mechanisms are not fully understood. Aim The present work attempted to elaborate the role of Wogonin during the process of psoriasis and to concentrate on the associated action mechanism. Methods Cell counting kit‐8 (CCK‐8) method was initially applied to assay the viability of human keratinocyte HaCaT cells treated by varying concentrations of Wogonin. To mimic psoriasis in vitro, HaCaT cells were exposed to M5 cytokines. CCK‐8 and 5‐Ethynyl‐2′‐deoxyuridine assays were adopted for the measurement of cell proliferation. Inflammatory levels were examined with enzyme‐linked immunosorbent assay. Immunofluorescence staining tested nucleotide‐binding oligomerization domain (NOD)‐like receptor family pyrin domain containing 3 (NLRP3) and Caspase‐1 expressions. Western blot examined the protein expressions of proliferation‐, inflammation‐, pyroptosis‐associated factors, and NLRP3. Results Wogonin treatment antagonized the proliferation, inflammatory response, and NLRP3/caspase‐1/Gasdermin‐D (GSDMD)‐mediated pyroptosis in M5‐challenged HaCaT cells. Besides, NLRP3 elevation partially abrogated the effects of Wogonin on M5‐induced proliferation, inflammatory response, and NLRP3/caspase‐1/GSDMD‐mediated pyroptosis in HaCaT cells. Conclusion In a word, Wogonin might exert anti‐proliferation, anti‐inflammatory and anti‐pyroptosis activities in M5‐induced cell model of psoriasis and the blockade of NLRP3/Caspase‐1/GSDMD pathway might be recognized as a potential mechanism underlying the protective mechanism of Wogonin in psoriasis, suggesting Wogonin as a prospective anti‐psoriasis drug.
Author Pan, Kai
Liu, Danqing
Ma, Jun
Sun, Yanhong
Ji, Chen
Wei, Yuegang
AuthorAffiliation 3 Department of Dermatology Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine Suzhou China
2 Department of Dermatology The Affiliated Zhangjiagang Hospital of Soochow University Suzhou China
1 First College of Clinical Medicine Nanjing University of Chinese Medicine Nanjing China
AuthorAffiliation_xml – name: 2 Department of Dermatology The Affiliated Zhangjiagang Hospital of Soochow University Suzhou China
– name: 1 First College of Clinical Medicine Nanjing University of Chinese Medicine Nanjing China
– name: 3 Department of Dermatology Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine Suzhou China
Author_xml – sequence: 1
  givenname: Jun
  surname: Ma
  fullname: Ma, Jun
  organization: The Affiliated Zhangjiagang Hospital of Soochow University
– sequence: 2
  givenname: Chen
  surname: Ji
  fullname: Ji, Chen
  email: Jichen820425@163.com
  organization: Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine
– sequence: 3
  givenname: Yanhong
  surname: Sun
  fullname: Sun, Yanhong
  organization: The Affiliated Zhangjiagang Hospital of Soochow University
– sequence: 4
  givenname: Danqing
  surname: Liu
  fullname: Liu, Danqing
  organization: The Affiliated Zhangjiagang Hospital of Soochow University
– sequence: 5
  givenname: Kai
  surname: Pan
  fullname: Pan, Kai
  organization: The Affiliated Zhangjiagang Hospital of Soochow University
– sequence: 6
  givenname: Yuegang
  orcidid: 0009-0000-1164-1485
  surname: Wei
  fullname: Wei, Yuegang
  email: Weiyg830824@163.com
  organization: Nanjing University of Chinese Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38967379$$D View this record in MEDLINE/PubMed
BookMark eNp1ksFu1DAQhiNUREvpgRdAlriA1O2O4zjJnhDahbJSRS8gjtYkGe-6TexgZ1vlxiPwODwPT4J3t1QtEqexx9__aWTN8-TAOktJ8pLDGQdIp8Y04owLEE-SoxQkTDKZFgcPzofJSQhXAMBBFALKZ8mhKGd5IYrZUfLrm1s5ayzDjlrjPA4U2LAm1nvXGk2xYZw9ZcbqFrsOB-dH5in0zgY6ZWgb1o_e9YMLJkSKXe8i1tXj1nRjkH2-XPz-8bM11xSDNUXUM42dacdtNEYa12EstbNDrMaumJjOMfQYKAb59BxDQ74zNt4WrMdhfYvji-SpxjbQyV09Tr5-_PBl_mlycXm-nL-_mNQil2IixQwrjQXOtEwzXZY55XmZoeAZVVkxA8yrVGoJmpOsIR4aEAKwKLNC6zQTx8ly720cXqnemw79qBwatWs4v1LoB1O3pEoAqmVFDUEVPz6tQDZS19EtKqwqiK53e1e_qTpqarKDx_aR9PGLNWu1cjeK8zSVUObR8ObO4N33DYVBdSbU1LZoyW2CElDkkAKXMqKv_0Gv3Mbb-FeRKmXOy7zYCt_uqdq7EDzp-2k4qO1-qe1-qe1-RfbVw_Hvyb_bFIHpHrg1LY3_N6nlciF2yj_82eKY
Cites_doi 10.1016/j.molimm.2023.06.007
10.1177/12034754241227623
10.1016/j.jdermsci.2007.01.001
10.1016/j.bcp.2015.02.002
10.1007/s00441-014-2105-4
10.1371/journal.pone.0293327
10.1186/s40659-020-00316-0
10.1093/nar/gky987
10.1007/s12010-017-2611-4
10.1007/s12192-023-01391-4
10.1016/j.plefa.2004.04.009
10.1016/j.intimp.2023.110811
10.1016/S0006-2952(03)00463-5
10.1080/07853890.2018.1453169
10.1142/S0192415X22500653
10.1007/s11033-020-05972-9
10.14715/cmb/2020.66.6.6
10.1002/eji.202250279
10.1111/jdv.13854
10.3390/ijms21041275
10.3390/ijms241713313
10.1016/S0014-2999(01)01187-6
10.3389/fmed.2022.712313
10.3389/fimmu.2023.1286344
10.1016/j.ejphar.2011.04.033
10.1146/annurev-immunol-081022-021207
10.1007/BF02980087
10.18097/pbmc20236906333
10.1097/FJC.0000000000001085
10.1097/MD.0000000000022400
10.1016/j.biopha.2022.113798
10.1186/s13045-023-01407-7
10.1016/j.jep.2022.115275
10.1155/2021/9935451
10.1007/s11434-016-1136-5
10.3390/ijms242216095
10.1016/j.brainresbull.2024.110886
ContentType Journal Article
Copyright 2024 The Author(s). published by John Wiley & Sons Ltd.
2024 The Author(s). Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024 The Author(s). published by John Wiley & Sons Ltd.
– notice: 2024 The Author(s). Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
– notice: 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
WIN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1002/iid3.1303
DatabaseName Wiley Open Access
Wiley Online Library Journals
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest - Health & Medical Complete保健、医学与药学数据库
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
CrossRef


MEDLINE - Academic
MEDLINE
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 7X7
  name: Health & Medical Complete (ProQuest Database)
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate MA et al
EISSN 2050-4527
EndPage n/a
ExternalDocumentID oai_doaj_org_article_800ec5bede0b4522b05d5fc50f3babb0
10_1002_iid3_1303
38967379
IID31303
Genre article
Journal Article
GrantInformation_xml – fundername: Natural Science Foundation for Young Scientists of Zhangjiagang TCM Hospital
  funderid: zzyq1902
– fundername: Youth Science and Technology Project of Zhangjiagang
  funderid: ZJGQNKJ202035; ZJGQNKJ202127
– fundername: Natural Science Foundation for Young Scientists of Zhangjiagang TCM Hospital
  grantid: zzyq1902
– fundername: Youth Science and Technology Project of Zhangjiagang
  grantid: ZJGQNKJ202127
– fundername: Youth Science and Technology Project of Zhangjiagang
  grantid: ZJGQNKJ202035
– fundername: Youth Science and Technology Project of Zhangjiagang
  grantid: ZJGQNKJ202035; ZJGQNKJ202127
GroupedDBID 0R~
1OC
24P
53G
5VS
7X7
8-1
8FI
8FJ
AAHHS
AAZKR
ABDBF
ABUWG
ACCFJ
ACXQS
ADBBV
ADKYN
ADRAZ
ADZMN
ADZOD
AEEZP
AEQDE
AFKRA
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
DIK
EBS
EJD
ESX
FYUFA
GODZA
GROUPED_DOAJ
HMCUK
HYE
IAO
IHR
INH
KQ8
M48
M~E
O9-
OK1
OVD
PIMPY
PQQKQ
PROAC
RPM
TEORI
UKHRP
WIN
CGR
CUY
CVF
ECM
EIF
ITC
NPM
AAYXX
CITATION
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c3653-539abfa7a9f524f886e6684a314eb4790a6b25f50f1e5c0f50d0330a7847ff243
IEDL.DBID RPM
ISSN 2050-4527
IngestDate Tue Oct 22 15:00:20 EDT 2024
Tue Sep 17 21:28:45 EDT 2024
Sat Aug 17 04:31:29 EDT 2024
Thu Oct 10 22:04:32 EDT 2024
Thu Sep 26 20:31:41 EDT 2024
Wed Oct 23 09:36:18 EDT 2024
Sat Aug 24 00:56:55 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords inflammatory response
pyroptosis
NOD‐like receptor family pyrin domain containing 3/Caspase‐1/Gasdermin‐D pathway
Wogonin
psoriasis
Language English
License Attribution
2024 The Author(s). Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3653-539abfa7a9f524f886e6684a314eb4790a6b25f50f1e5c0f50d0330a7847ff243
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0009-0000-1164-1485
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11225086/
PMID 38967379
PQID 3085618676
PQPubID 2034588
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_800ec5bede0b4522b05d5fc50f3babb0
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11225086
proquest_miscellaneous_3076020155
proquest_journals_3085618676
crossref_primary_10_1002_iid3_1303
pubmed_primary_38967379
wiley_primary_10_1002_iid3_1303_IID31303
PublicationCentury 2000
PublicationDate July 2024
PublicationDateYYYYMMDD 2024-07-01
PublicationDate_xml – month: 07
  year: 2024
  text: July 2024
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Bognor Regis
– name: Hoboken
PublicationTitle Immunity, Inflammation and Disease
PublicationTitleAlternate Immun Inflamm Dis
PublicationYear 2024
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2022; 155
2015; 360
2022; 294
2023; 14
2018; 184
2023; 18
2004; 27
2022; 50
2023; 161
2015; 94
2024; 207
2023; 124
2024; 54
2023; 108
2020; 99
2001; 425
2017; 31
2023; 41
2023; 24
2023; 69
2021; 78
2021; 11
2023; 28
2020; 53
2022; 9
2019; 47
2020; 47
2016; 61
2020; 66
2018; 50
2005; 72
2020; 21
2023b; 16
2024; 28
2007; 46
2011; 661
2021; 2021
2003; 66
e_1_2_9_30_1
e_1_2_9_31_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_14_1
e_1_2_9_39_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_19_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_20_1
e_1_2_9_40_1
e_1_2_9_22_1
e_1_2_9_24_1
e_1_2_9_23_1
e_1_2_9_8_1
e_1_2_9_7_1
e_1_2_9_6_1
e_1_2_9_5_1
Chuo WH (e_1_2_9_21_1) 2021; 11
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_9_1
e_1_2_9_26_1
e_1_2_9_25_1
e_1_2_9_28_1
e_1_2_9_27_1
e_1_2_9_29_1
Garner KK (e_1_2_9_2_1) 2023; 108
References_xml – volume: 66
  start-page: 1271
  year: 2003
  end-page: 1278
  article-title: Effects of Wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation‐associated gene expression
  publication-title: Biochem Pharmacol
– volume: 21
  start-page: 1275
  year: 2020
  article-title: Interleukin‐17A and keratinocytes in psoriasis
  publication-title: Int J Mol Sci
– volume: 184
  start-page: 1073
  year: 2018
  end-page: 1093
  article-title: Enhancement of protective effects of radix Scutellariae on UVB‐induced photo damage in human HaCaT keratinocytes
  publication-title: Appl Biochem Biotechnol
– volume: 16
  year: 2023b
  article-title: Involvement of inflammasomes in tumor microenvironment and tumor therapies
  publication-title: J Hematol Oncol
– volume: 14
  year: 2023
  article-title: Crosstalk: keratinocytes and immune cells in psoriasis
  publication-title: Front Immunol
– volume: 53
  year: 2020
  article-title: Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod‐induced psoriasis‐like skin lesion in mice
  publication-title: Biol Res
– volume: 24
  year: 2023
  article-title: Challenges and future trends in the treatment of psoriasis
  publication-title: Int J Mol Sci
– volume: 72
  start-page: 59
  year: 2005
  end-page: 66
  article-title: Suppression of cyclooxygenase‐2 expression of skin fibroblasts by Wogonin, a plant flavone from Scutellaria radix
  publication-title: Prostaglandins, Leukot Essent Fatty Acids
– volume: 360
  start-page: 583
  year: 2015
  end-page: 589
  article-title: Keratins and skin disease
  publication-title: Cell Tissue Res
– volume: 66
  start-page: 29
  year: 2020
  end-page: 33
  article-title: Wogonin suppresses proliferation and invasion of skin epithelioid carcinoma cells through Notch1
  publication-title: Cell Mol Biol
– volume: 661
  start-page: 124
  year: 2011
  end-page: 132
  article-title: Effects of baicalein and wogonin isolated from Scutellaria baicalensis roots on skin damage in acute UVB‐irradiated hairless mice
  publication-title: Eur J Pharmacol
– volume: 11
  start-page: 616
  year: 2021
  article-title: Alantolactone suppresses proliferation and the inflammatory response in human HaCaT keratinocytes and ameliorates Imiquimod‐Induced skin lesions in a psoriasis‐like mouse model
  publication-title: Life (Basel)
– volume: 9
  year: 2022
  article-title: Novel therapeutic target(s) for psoriatic disease
  publication-title: Front Med
– volume: 124
  year: 2023
  article-title: Analysis of the potential pyroptosis mechanism in psoriasis and experimental validation of NLRP3 in vitro and in vivo
  publication-title: Int Immunopharmacol
– volume: 61
  start-page: 1391
  year: 2016
  end-page: 1398
  article-title: Scutellaria baicalensis, the golden herb from the garden of Chinese medicinal plants
  publication-title: Sci Bulletin
– volume: 28
  start-page: 989
  year: 2023
  end-page: 999
  article-title: Wogonin attenuates inflammation and oxidative stress in lipopolysaccharide‐induced mastitis by inhibiting Akt/NF‐κB pathway and activating the Nrf2/HO‐1 signaling
  publication-title: Cell Stress Chaperones
– volume: 78
  start-page: 597
  year: 2021
  end-page: 603
  article-title: Wogonin alleviates cisplatin‐induced cardiotoxicity in mice via inhibiting gasdermin d‐mediated pyroptosis
  publication-title: J Cardiovasc Pharmacol
– volume: 207
  year: 2024
  article-title: Wogonin alleviates NLRP3 inflammasome activation after cerebral ischemia‐reperfusion injury by regulating AMPK/SIRT1
  publication-title: Brain Res Bull
– volume: 155
  year: 2022
  article-title: Therapeutic efficacy of Scutellaria baicalensis Georgi against psoriasis‐like lesions via regulating the responses of keratinocyte and macrophage
  publication-title: Biomed Pharmacother
– volume: 28
  start-page: NP19
  year: 2024
  end-page: NP35
  article-title: Interleukins and psoriasis
  publication-title: J Cutan Med Surg
– volume: 47
  start-page: D976
  year: 2019
  end-page: D982
  article-title: ETCM: an encyclopaedia of traditional Chinese medicine
  publication-title: Nucleic Acids Res
– volume: 41
  start-page: 301
  year: 2023
  end-page: 316
  article-title: Structural mechanisms of NLRP3 inflammasome assembly and activation
  publication-title: Annu Rev Immunol
– volume: 50
  start-page: 323
  year: 2018
  end-page: 332
  article-title: Deciphering metabonomics biomarkers‐targets interactions for psoriasis vulgaris by network pharmacology
  publication-title: Ann Med
– volume: 46
  start-page: 31
  year: 2007
  end-page: 40
  article-title: Wogonin suppresses TARC expression induced by mite antigen via heme oxygenase 1 in human keratinocytes
  publication-title: J Dermatol Sci
– volume: 47
  start-page: 9779
  year: 2020
  end-page: 9789
  article-title: Potential therapeutic and pharmacological effects of Wogonin: an updated review
  publication-title: Mol Biol Rep
– volume: 108
  start-page: 562
  year: 2023
  end-page: 573
  article-title: Psoriasis: recognition and management strategies
  publication-title: Am Fam Physician
– volume: 31
  start-page: 205
  year: 2017
  end-page: 212
  article-title: A systematic review of worldwide epidemiology of psoriasis
  publication-title: J Eur Acad Dermatol Venereol
– volume: 99
  year: 2020
  article-title: Chinese herbal medicine for psoriasis: protocol for an overview of systematic reviews
  publication-title: Medicine
– volume: 2021
  start-page: 1
  year: 2021
  end-page: 9
  article-title: The therapeutic potential of Wogonin observed in preclinical studies
  publication-title: J Evid Based Complementary Altern Med
– volume: 69
  start-page: 333
  year: 2023
  end-page: 352
  article-title: Redox regulation of the NLRP3‐mediated inflammation and pyroptosis
  publication-title: Biomed Khim
– volume: 425
  start-page: 153
  year: 2001
  end-page: 157
  article-title: Inhibition of TPA‐induced cyclooxygenase‐2 expression and skin inflammation in mice by Wogonin, a plant flavone from Scutellaria radix
  publication-title: Eur J Pharmacol
– volume: 54
  year: 2024
  article-title: Keratinocytes in the pathogenesis, phenotypic switch, and relapse of psoriasis
  publication-title: Eur J Immunol
– volume: 50
  start-page: 1553
  year: 2022
  end-page: 1564
  article-title: Wogonin ameliorated obesity‐induced lipid metabolism disorders and cardiac injury via suppressing pyroptosis and deactivating IL‐17 signaling pathway
  publication-title: Am J Chin Med (Gard City N Y)
– volume: 24
  year: 2023
  article-title: Inflammation and psoriasis: a comprehensive review
  publication-title: Int J Mol Sci
– volume: 18
  year: 2023
  article-title: Circulating inflammatory cytokines and psoriasis risk: a systematic review and meta‐analysis
  publication-title: PLoS One
– volume: 161
  start-page: 44
  year: 2023
  end-page: 60
  article-title: Potential roles of inflammasomes in the pathophysiology of psoriasis: a comprehensive review
  publication-title: Mol Immunol
– volume: 294
  year: 2022
  article-title: Potential effects and mechanisms of Chinese herbal medicine in the treatment of psoriasis
  publication-title: J Ethnopharmacol
– volume: 27
  start-page: 442
  year: 2004
  end-page: 448
  article-title: Inhibition of contact dermatitis in animal models and suppression of proinflammatory gene expression by topically applied flavonoid, wogonin
  publication-title: Arch Pharmacal Res
– volume: 94
  start-page: 142
  year: 2015
  end-page: 154
  article-title: Wogonoside protects against dextran sulfate sodium‐induced experimental colitis in mice by inhibiting NF‐κB and NLRP3 inflammasome activation
  publication-title: Biochem Pharmacol
– ident: e_1_2_9_20_1
  doi: 10.1016/j.molimm.2023.06.007
– ident: e_1_2_9_6_1
  doi: 10.1177/12034754241227623
– ident: e_1_2_9_22_1
  doi: 10.1016/j.jdermsci.2007.01.001
– ident: e_1_2_9_37_1
  doi: 10.1016/j.bcp.2015.02.002
– ident: e_1_2_9_30_1
  doi: 10.1007/s00441-014-2105-4
– ident: e_1_2_9_5_1
  doi: 10.1371/journal.pone.0293327
– ident: e_1_2_9_32_1
  doi: 10.1186/s40659-020-00316-0
– ident: e_1_2_9_7_1
  doi: 10.1093/nar/gky987
– ident: e_1_2_9_29_1
  doi: 10.1007/s12010-017-2611-4
– ident: e_1_2_9_13_1
  doi: 10.1007/s12192-023-01391-4
– ident: e_1_2_9_26_1
  doi: 10.1016/j.plefa.2004.04.009
– ident: e_1_2_9_38_1
  doi: 10.1016/j.intimp.2023.110811
– ident: e_1_2_9_15_1
  doi: 10.1016/S0006-2952(03)00463-5
– ident: e_1_2_9_33_1
  doi: 10.1080/07853890.2018.1453169
– volume: 11
  start-page: 616
  year: 2021
  ident: e_1_2_9_21_1
  article-title: Alantolactone suppresses proliferation and the inflammatory response in human HaCaT keratinocytes and ameliorates Imiquimod‐Induced skin lesions in a psoriasis‐like mouse model
  publication-title: Life (Basel)
  contributor:
    fullname: Chuo WH
– ident: e_1_2_9_41_1
  doi: 10.1142/S0192415X22500653
– ident: e_1_2_9_11_1
  doi: 10.1007/s11033-020-05972-9
– ident: e_1_2_9_25_1
  doi: 10.14715/cmb/2020.66.6.6
– volume: 108
  start-page: 562
  year: 2023
  ident: e_1_2_9_2_1
  article-title: Psoriasis: recognition and management strategies
  publication-title: Am Fam Physician
  contributor:
    fullname: Garner KK
– ident: e_1_2_9_24_1
  doi: 10.1002/eji.202250279
– ident: e_1_2_9_3_1
  doi: 10.1111/jdv.13854
– ident: e_1_2_9_35_1
  doi: 10.3390/ijms21041275
– ident: e_1_2_9_4_1
  doi: 10.3390/ijms241713313
– ident: e_1_2_9_16_1
  doi: 10.1016/S0014-2999(01)01187-6
– ident: e_1_2_9_34_1
  doi: 10.3389/fmed.2022.712313
– ident: e_1_2_9_23_1
  doi: 10.3389/fimmu.2023.1286344
– ident: e_1_2_9_27_1
  doi: 10.1016/j.ejphar.2011.04.033
– ident: e_1_2_9_18_1
  doi: 10.1146/annurev-immunol-081022-021207
– ident: e_1_2_9_36_1
  doi: 10.1007/BF02980087
– ident: e_1_2_9_39_1
  doi: 10.18097/pbmc20236906333
– ident: e_1_2_9_40_1
  doi: 10.1097/FJC.0000000000001085
– ident: e_1_2_9_9_1
  doi: 10.1097/MD.0000000000022400
– ident: e_1_2_9_28_1
  doi: 10.1016/j.biopha.2022.113798
– ident: e_1_2_9_17_1
  doi: 10.1186/s13045-023-01407-7
– ident: e_1_2_9_19_1
  doi: 10.1016/j.intimp.2023.110811
– ident: e_1_2_9_8_1
  doi: 10.1016/j.jep.2022.115275
– ident: e_1_2_9_12_1
  doi: 10.1155/2021/9935451
– ident: e_1_2_9_10_1
  doi: 10.1007/s11434-016-1136-5
– ident: e_1_2_9_31_1
  doi: 10.3390/ijms242216095
– ident: e_1_2_9_14_1
  doi: 10.1016/j.brainresbull.2024.110886
SSID ssj0001037308
Score 2.3215494
Snippet Background Psoriasis refers to a highly prevalent and immunologically mediated dermatosis with considerable deterioration in life quality. Wogonin, a sort of...
Psoriasis refers to a highly prevalent and immunologically mediated dermatosis with considerable deterioration in life quality. Wogonin, a sort of flavonoid,...
Abstract Background Psoriasis refers to a highly prevalent and immunologically mediated dermatosis with considerable deterioration in life quality. Wogonin, a...
Background Psoriasis refers to a highly prevalent and immunologically mediated dermatosis with considerable deterioration in life quality. Wogonin, a sort of...
Wogonin was capable of alleviating the hyperproliferation, inflammatory response as well as pyroptosis in HaCaT keratinocytes exposed to M5 cytokines, the...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e1303
SubjectTerms Caspase 1 - metabolism
Cell growth
Cell Line
Cell Proliferation - drug effects
Chemokines
Chinese medicine
Cytokines
Flavanones - pharmacology
Gasdermins
HaCaT Cells
Herbal medicine
Humans
Inflammation - drug therapy
Inflammation - metabolism
inflammatory response
Intracellular Signaling Peptides and Proteins - metabolism
Ischemia
Keratin
Keratinocytes - drug effects
Keratinocytes - metabolism
Ligands
NLR Family, Pyrin Domain-Containing 3 Protein - metabolism
NOD‐like receptor family pyrin domain containing 3/Caspase‐1/Gasdermin‐D pathway
Original
Phosphate-Binding Proteins
Proteins
Psoriasis
Psoriasis - drug therapy
Psoriasis - metabolism
Psoriasis - pathology
pyroptosis
Pyroptosis - drug effects
Reagents
Signal Transduction - drug effects
Software
Tumor necrosis factor-TNF
Wogonin
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dbtMwFLbQpEncIBh_gYEM4oKLRXXjnziXsDI2JMYNE7uL7MRm0dakajqm3u0R9jh7Hp6Ec-y2agWIG66aNj6Jm_M5_mwfn4-QN1o44U2GK4zapsIKaHNZVacVjA0KJ422OW4U_nysDk_Ep1N5uib1hTFhMT1wfHADIDSuktbVjlnM_m2ZrKWvJPPcGmvjaH0o1wZTYXaFcYCuXqYSYtmgaWqO0sd8owMKefr_RC5_j5Fc566h8zm4T-4tWCN9F2v7gNxx7Q7ZjjqS84fk9lv3HadVqRm7C9xzD_yRArOjE9Tk8S56eY8CmgAA47CwTqcxOtbtUdPWdDKfdpNZ1zc9lKLnwaTtqjle6Udj6PGX0c_rm4vm3IEhhsJ0UxonR9AUTOpubOADQ9-j6ATlg30D76vegeFw8NH0dQi8gW8jikLIV2b-iJwcfPi6f5guJBnSiivJU8kLY73JTeFlJrzWyimlheFD4azIC2aUzaQH7wydrBgc1IxzZnLoBL3PBH9MttqudU8JBd5U1cA-PcsKIXNrvcZZVW15paxUJiGvl34qJzHzRhlzLGclOhMX4nhC3qMHVwUwWXb4ASBULiBU_gtCCdld-r9ctOC-BPRI1BLIVUJerU5D28MFFdO67hLL5AroNlCyhDyJcFnVBIggSgAVCdEbQNqo6uaZtjkL-b2BAgMx1XDjtwFzf__75dHRiOPBs__xHJ6TuxlQthiMvEu2ZtNL9wIo18y-DK3rF4MWMdw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELagFRIXxH8DBRnEgUOj9cZ24pwQ7ba0SCwIUdFbZMd2idpNQrIF7Y1H4HF4Hp6EmSS7ZcXPKcnGs-toZuxvZybzEfJMCSe8jjDDqEwojACfi3Ib5vDfIHVSK5Pgi8JvpvHhsXh9Ik-GgFs7lFUu18RuobZVjjHyEQdsgL3dk_hF_TlE1ijMrg4UGlfJZjQWmKbd3N2fvnt_GWVhHExYLVsKsWhUFJYjBTJf24i6fv1_A5l_1kr-jmG7TejgJrkxoEf6slf3LXLFlbfJtZ5PcnGH_PhYnWJ4leqZO8d37wFHUkB4tEZuHu96be9QsCowhFmXYKdNXyXrdqguLa0XTVXPq7ZoYRQ960TKKl_gN30pNJ2-nfz89v28OHMgiCUxVUP7IAmKgoitZhoOWALfk09QPtrTsG61DgTHo1e6tV0BDlxNKBIif9WLu-T4YP_D3mE4UDOEOY8lDyVPtfE60amXkfBKxS6OldB8LJwRScp0bCLpJfNjJ3MGJ5ZxznQCm6H3keD3yEZZlW6LUMBPuQUU6lmUCpkY4xVGV5XheWxkrAPydKmnrO47cGR9r-UoQ2ViQo4HZBc1uBqATbO7D6rmNBt8MANs7HJpnHXMYCN5w6SVPodJcqONYQHZXuo_Gzy5zS7tLiBPVrfBBzGxoktXXeCYJAbYDdAsIPd7c1nNBAAhUgGlAVFrhrQ21fU7ZfGp6_MNUBgAqoIfft7Z3L8fPzs6mnA8efD_R3hIrkcAyvpy422yMW8u3CMAVXPzePCcX7WsKXY
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKERIXxJvQggziwKFhvfEjyQEh6FJapJYLK3qL7MQuUXeTbbIF8rf4hcw42VVXFIlTrNiTOJmZ-Is9no-QV4mwwukIVxgTEwojwOeivAhz-DdIrdSJiXGj8PGJOpyKz6fydIusODaHF9he-2uHfFLTZvbm10X3Dhz-7ZBAdFSWBUdWY36D3IwEF2joxwPK91MtjIMde246JlkoZBSvcgxdld4YmXwC_-tQ59_Bk1dBrR-VDu6SOwOcpO97_d8jW7a6T271BJPdA_L7W32G861Uz-0MN-MDsKQA-egCyXqc7dW_R-HBwTLmfsWdNn3YrN2juiroomvqxbJuyxZa0XMvUtV5h1f6UWp68mUSzspzC2IYIVM3tJ8zQUEQKOq5hgNGxPdcFJSP9jV8xlobjkefdFv4aJxwQpEb-afuHpLpwcev-4fhwNIQ5lxJHkqeauN0rFMnI-GSRFmlEqH5WFgj4pRpZSLpJHNjK3MGhYJxznQM46JzoK9HZLuqK_uEUIBSeQGA1LEoFTI2xiU40ZoYnisjlQ7Iy5WGskWfjCPr0y5HGaoR1-Z4QD6g7tYNMH-2P1E3Z9ngjhnAZJtLYwvLDOaUN0wW0uXQSW60MSwguyvNZyubzMCGJNILxCogL9bV4I64xqIrW19im1gBAgeUFpDHvaGsewLYEFmB0oAkGya00dXNmqr87lN-AyoGrJrAjV97a_v342dHRxOOhaf_0ccdcjsCkNaHH--S7WVzaZ8ByFqa596F_gAr-yg0
  priority: 102
  providerName: Scholars Portal
– databaseName: Wiley Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NjtMwELaWRUhcEP8EFmQQBw4b1fVP4ogTbFl2kVg4sGJvkZ3YS7Q0qZIuqDcegcfheXgSZuy2SwVInJo2ntbRzMRfx5PvI-Splk56w3GHUdtUWgk5x6s6reC_QeGU0TbHB4XfHmUHx_LNiTrZIs9Xz8JEfoh1wQ0zI9yvMcGNHUYXpKFNUwvUMhaXyGWANRpDmsv3FwUWJiB6gyIdUyyViucrZiHGR2vrjfUo0Pb_DWv-2TL5O5QNa9H-dXJtCSLpi-j1G2TLtTfJlSgrubhFfnzsTrHKSs0UrhF97AYKQI_OUKLHu-j0XQrBBfEwDfvstI_Nsm6Xmrams0Xfzebd0Awwip4Fk7arFvhNXxpDj95Nfn77_rk5c2CInTFdT2OtBE3BpO6mBl6wEz5qUFAx2jNw-xocGI5Hr81Qhz4ceDehqIv81Sxuk-P9Vx_2DtKlQkNaiUyJVInCWG9yU3jFpdc6c1mmpRFj6azMC2Yyy5VXzI-dqhgc1EwIZnJYE73nUtwh223XunuEAoyqagCjnvFCqtxar7HIqq2oMqsyk5AnKz-Vs0jEUUbKZV6iM3FfTiTkJXpwPQC5s8MHXX9aLlOxBIjsKmVd7ZhFPnnLVK18BZMU1ljLErKz8n-5TOihhEhSKC2QZwl5vD4NqYj7K6Z13TmOyTNA34DQEnI3hst6JoALURGoSIjeCKSNqW6eaZtPge4bEDHgVA0__CzE3L8vvzw8nAg8uP__Qx-QqxxwWuxA3iHb8_7cPQScNbePQj79AlJiKbs
  priority: 102
  providerName: Wiley-Blackwell
Title Wogonin ameliorates the proliferation, inflammatory response, and pyroptosis in keratinocytes via NOD‐like receptor family pyrin domain containing 3/Caspase‐1/Gasdermin‐D pathway
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fiid3.1303
https://www.ncbi.nlm.nih.gov/pubmed/38967379
https://www.proquest.com/docview/3085618676
https://www.proquest.com/docview/3076020155/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC11225086
https://doaj.org/article/800ec5bede0b4522b05d5fc50f3babb0
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NjtMwELa2i5C4IP4JLJVBHDhst2n8E-fItrvsIrVUiBW9RXZiL9G2SdV2Qb3xCDwOz8OTMOM01VbAhUuSNp7W0XzOfB6PZwh5rbjlTke4wqhMhxsOYy7K8k4Gc4PECq1MjBuFhyN5dsHfT8Rkj8hmL4wP2s9McVROZ0dl8cXHVs5nWbeJE-uOh33gCGC5ley2SCtm7MYc3XtWQgawVU0aoTDqFkXOsOwxFs0BA42lWZIdO-TT9f-NY_4ZKnmTwnobdHqP3N2QR_q27uR9smfLB-R2XU5y_ZD8_FxdoneV6pmd4tZ7oJEUCB6dY2keZ2tlH1IAFeBg5tfX6aIOkrWHVJc5na8X1XxVLYsltKJXXqSssjX-0tdC09GHwa_vP6bFlQVBjIipFrT2kaAoiOTVTMMJI-Dr2hOUdfsaXltLC4K97ju9zH38DXwaUKyH_E2vH5GL05NP_bPOpjJDJ2NSsI5giTZOxzpxIuJOKWmlVFyzHreGx0mopYmEE6HrWZGFcJGHjIU6BlvoXMTZY7JfVqV9SijQpywHEurCKOEiNsYpdK4qwzJphNQBedXoKZ3XCTjSOtVylKJecT2OBeQYNbhtgDmz_RfV4jLdICcFamwzYWxuQ4N55E0ocuEy6CQz2pgwIAeN_tPNQF6mACSBJQViGZCX29swBHFdRZe2usY2sQTWDcwsIE9quGx70sAtIGoHSDtd3b0DqPdpvhuUB-SNx9y_Hz89Px8wvHj2___ynNyJgK_VkcgHZH-1uLYvgG-tTJu0Ij6GYzyJ2-TW8clo_LHtfRdwHHLV9sPvN6yRNoo
link.rule.ids 230,315,733,786,790,870,891,2115,2236,11589,12083,21416,24346,27955,27956,31752,31753,33777,33778,43343,43838,46085,46509,50847,50956,53825,53827,74100,74657
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NctMwENZAGQYuDL_FUEAwHDjUE8WSbPnEQENJoA2XdsjNI9lS8bSxjZ3C5MYj8Dg8D0_Cru2kZPg52Y61iTy7K33ZXe9HyHMlrHA6wAyjMr4wAnwuSDM_hf8GsZVamQhfFD6chuNj8W4mZ33ArenLKldrYrtQZ2WKMfIBB2yAvd2j8GX12UfWKMyu9hQal8kVwblAO49m0UWMhXEwYLVqKMSCQZ5nHAmQ-cY21Hbr_xvE_LNS8ncE225B-zfJjR470ledsm-RS7a4Ta52bJLLO-THx_IEg6tUz-0ZvnkPKJICvqMVMvM42-l6l4JNgRnM2_Q6rbsaWbtLdZHRalmX1aJs8gZG0dNWpCjTJX7Tl1zT6YfRz2_fz_JTC4JYEFPWtAuRoCiIZOVcwwEL4DvqCcoHexpWrcaC4HDwVjdZW34DVyOKdMhf9fIuOd5_c7Q39ntiBj_loeS-5LE2Tkc6djIQTqnQhqESmg-FNSKKmQ5NIJ1kbmhlyuAkY5wzHcFW6Fwg-D2yVZSFvU8ooKc0AwzqWBALGRnjFMZWleFpaGSoPfJspaek6vpvJF2n5SBBZWI6jnvkNWpwPQBbZrcflPVJ0ntgAsjYptLYzDKDbeQNk5l0KUySG20M88jOSv9J78dNcmF1Hnm6vg0eiGkVXdjyHMdEIYBuAGYe2e7MZT0TgINIBBR7RG0Y0sZUN-8U-ae2yzcAYYCnCn74RWtz_378ZDIZcTx58P9HeEKujY8OD5KDyfT9Q3I9AHjWFR7vkK1FfW4fAbxamMetD_0C5Hsq_Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NctMwENZAGRguHX6LoYBgOHCox4ol2fKJgYbQ8BM40CE3j2RLxdPGduMUJjcegcfheXgSdm0nJcPPyXasTeTZXenL7no_Qp4oYYXTIWYYlfGFEeBzYZb7Gfw3SKzUysT4ovC7SXRwKF5P5bSvf2r6ssrVmtgu1HmVYYw84IANsLd7HAWuL4v4MBw9q099ZJDCTGtPp3GRXIJdkiGNQzyNz-MtjIMxq1VzIRYGRZFzJEPmG1tS27n_b3Dzz6rJ39Fsux2NrpHtHkfS553ir5MLtrxBLnfMksub5Men6ggDrVTP7Am-hQ-IkgLWozWy9Djb6X2Pgn2BSczaVDudd_Wydo_qMqf1cl7Vi6opGhhFj1uRssqW-E1fCk0n74c_v30_KY4tCGJxTDWnXbgERUEkr2YaDlgM39FQUB7sa1jBGguCg-CVbvK2FAeuhhSpkb_q5S1yOHr5cf_A70ka_IxHkvuSJ9o4HevEyVA4pSIbRUpoPhDWiDhhOjKhdJK5gZUZg5Occc50DNuic6Hgt8lWWZX2DqGApLIc8KhjYSJkbIxTGGdVhmeRkZH2yOOVntK668WRdl2XwxSViak57pEXqMH1AGyf3X5QzY_S3htTQMk2k8bmlhlsKW-YzKXLYJLcaGOYR3ZX-k97n27Scwv0yKP1bfBGTLHo0lZnOCaOAIADSPPITmcu65kANERSoMQjasOQNqa6eacsPrcdvwEUA1RV8MNPW5v79-On4_GQ48nd_z_CQ3IF3Cd9O568uUeuhoDUuhrkXbK1mJ_Z-4C0FuZB60K_AHwtLyk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Wogonin+ameliorates+the+proliferation%2C+inflammatory+response%2C+and+pyroptosis+in+keratinocytes+via+NOD-like+receptor+family+pyrin+domain+containing+3%2FCaspase-1%2FGasdermin-D+pathway&rft.jtitle=Immunity%2C+Inflammation+and+Disease&rft.au=Ma%2C+Jun&rft.au=Ji%2C+Chen&rft.au=Sun%2C+Yanhong&rft.au=Liu%2C+Danqing&rft.date=2024-07-01&rft.issn=2050-4527&rft.eissn=2050-4527&rft.volume=12&rft.issue=7&rft.spage=e1303&rft_id=info:doi/10.1002%2Fiid3.1303&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2050-4527&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2050-4527&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2050-4527&client=summon